Ongoing state attorney general antitrust litigation is the dominant factor anchoring trader sentiment, with a federal judge issuing a temporary restraining order in July 2026 that prompted Paramount and Warner Bros. Discovery to agree to pause the $111 billion deal until June 2027 or case resolution. While the U.S. Department of Justice, European Commission, and several other regulators cleared the transaction earlier in the year, the multi-state challenge has shifted the original Q3 2026 target well beyond year-end. Traders view the extended timeline, potential trial delays into 2027, and risk of injunction or settlement as significant barriers, outweighing prior milestones like shareholder approval.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$137,308 Vol.
$137,308 Vol.
$137,308 Vol.
$137,308 Vol.
Resolution will be based on official company communications and regulatory filings from Paramount and Warner Bros. Discovery (or any successor entities), supplemented as needed by a consensus of reporting from major reputable news outlets.
Market Opened: Dec 8, 2025, 11:30 AM ET
Resolver
0x65070BE91...Resolution will be based on official company communications and regulatory filings from Paramount and Warner Bros. Discovery (or any successor entities), supplemented as needed by a consensus of reporting from major reputable news outlets.
Resolver
0x65070BE91...Ongoing state attorney general antitrust litigation is the dominant factor anchoring trader sentiment, with a federal judge issuing a temporary restraining order in July 2026 that prompted Paramount and Warner Bros. Discovery to agree to pause the $111 billion deal until June 2027 or case resolution. While the U.S. Department of Justice, European Commission, and several other regulators cleared the transaction earlier in the year, the multi-state challenge has shifted the original Q3 2026 target well beyond year-end. Traders view the extended timeline, potential trial delays into 2027, and risk of injunction or settlement as significant barriers, outweighing prior milestones like shareholder approval.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions